Mediheal Group of Hospitals has strongly denied recent allegations linking it to a kidney organ harvesting syndicate, maintaining that its operations have always adhered to legal and ethical medical standards.
In a press briefing on Wednesday, the hospital revealed it has successfully conducted 476 kidney transplants since 2018, with an impressive 98% success rate and only two recorded fatalities. Out of these procedures, 371 involved Kenyan patients while 105 were foreign nationals.
“This is a clear indication of our commitment to saving lives,” the hospital said in a statement. “All transplants were conducted in strict compliance with the set medical procedures and regulatory guidelines.”
The hospital’s legal counsel, Katwa Kigen, dismissed the allegations as baseless and malicious, stating that they were a calculated attempt to tarnish the hospital’s image. He emphasized Mediheal’s readiness to cooperate fully with investigative bodies probing the claims.
“Our books are open. We have nothing to hide,” Kigen asserted.
Dr. Swarup Mishra, the Chairperson of Mediheal’s Board — who was recently suspended by President William Ruto as Chairperson of the Kenya Biovax Institute — also addressed the matter. He said he is willing to take full responsibility if investigations prove any wrongdoing by the institution.
“If the hospital is found culpable in any way, I will not run away from accountability,” Dr. Mishra said.
The hospital’s statement comes as the National Assembly’s Departmental Committee on Health announced plans to launch a formal inquiry into the matter. The committee is expected to summon key stakeholders as it investigates the claims that have sparked public concern.
The controversy has brought renewed attention to organ transplant regulations in Kenya, as well as the oversight mechanisms in place to prevent potential abuses. Mediheal has vowed to uphold its commitment to transparency and patient safety throughout the inquiry process.